高级检索
当前位置: 首页 > 详情页

Incidence and progression of diabetic retinopathy: a systematic review

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore [2]Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore [3]Duke-NUS Medical School, National University of Singapore, Singapore [4]Yong Loo Lin School of Medicine, National University of Singapore, Singapore [5]Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, and Beijing Ophthalmology & Visual Sciences Key Laboratory, Beijing, China [6]Department of Ophthalmology, Medical Faculty Mannheim of the Ruprecht-Karls-University Heidelberg, Mannheim, Germany [7]Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA [8]Centre for Vision Research, University of Sydney, Sydney, NSW, Australia
出处:
ISSN:

摘要:
Diabetic retinopathy is a leading cause of vision impairment and blindness. We systematically reviewed studies published from Jan 1, 1980, to Jan 7, 2018, assessed the methodological quality, and described variations in incidence of diabetic retinopathy by region with a focus on population-based studies that were conducted after 2000 (n= 8, including two unpublished studies). Of these eight studies, five were from Asia, and one each from the North America, Caribbean, and sub-Saharan Africa. The annual incidence of diabetic retinopathy ranged from 2.2% to 12.7% and progression from 3.4% to 12.3%. Progression to proliferative diabetic retinopathy was higher in individuals with mild disease compared with those with no disease at baseline. Our Review suggests that more high-quality population-based studies capturing data on the incidence and progression of diabetic retinopathy with stratification by age and sex are needed to consolidate the evidence base. Our data is useful for conceptualisation and development of major public health strategies such as screening programmes for diabetic retinopathy.

基金:
语种:
高被引:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 1 区 医学
小类 | 1 区 内分泌学与代谢
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 内分泌学与代谢
JCR分区:
出版当年[2017]版:
Q1 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q1 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore [2]Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore [3]Duke-NUS Medical School, National University of Singapore, Singapore
通讯作者:
通讯机构: [1]Singapore Eye Research Institute, Singapore National Eye Centre, Singapore [2]Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore [3]Duke-NUS Medical School, National University of Singapore, Singapore [4]Yong Loo Lin School of Medicine, National University of Singapore, Singapore [*1]Singapore National Eye Centre, Singapore 168751
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:23418 今日访问量:3 总访问量:1279 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)